These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36439119)

  • 1. Adjuvant alternative cytokine-induced killer cell combined with natural killer cell immunotherapy improves the prognosis of post-mastectomy breast cancer.
    Yang X; Weng D; Pan Q; Xiang T; Yang C; Wu Z; Li M; Xie S; Tang Y; Xia J; Zhao J
    Front Immunol; 2022; 13():974487. PubMed ID: 36439119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical activity of adjuvant cytokine-induced killer cell immunotherapy in patients with post-mastectomy triple-negative breast cancer.
    Pan K; Guan XX; Li YQ; Zhao JJ; Li JJ; Qiu HJ; Weng DS; Wang QJ; Liu Q; Huang LX; He J; Chen SP; Ke ML; Zeng YX; Xia JC
    Clin Cancer Res; 2014 Jun; 20(11):3003-11. PubMed ID: 24668644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adoptive cell therapy of triple negative breast cancer with redirected cytokine-induced killer cells.
    Sommaggio R; Cappuzzello E; Dalla Pietà A; Tosi A; Palmerini P; Carpanese D; Nicolè L; Rosato A
    Oncoimmunology; 2020 Jun; 9(1):1777046. PubMed ID: 32923140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of FAK inhibitor and cytokine-induced killer cell therapy: An alternative therapeutic strategy for patients with triple-negative breast cancer.
    Wu CC; Pan MR; Shih SL; Shiau JP; Wu CC; Chang SJ; Kao CN; Chen FM; Hou MF; Luo CW
    Biomed Pharmacother; 2023 Jul; 163():114732. PubMed ID: 37254289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant cellular immunotherapy in patients with resected primary non-small cell lung cancer.
    Pan QZ; Tang Y; Wang QJ; Li YQ; Zhang L; Li XD; Zhao JJ; Weng DS; Liu Q; Huang LX; He J; Chen SP; Ke ML; Zeng YX; Xia JC
    Oncoimmunology; 2015 Sep; 4(9):e1038017. PubMed ID: 26405607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD-L1 expression is a predictive biomarker for CIK cell-based immunotherapy in postoperative patients with breast cancer.
    Zhou ZQ; Zhao JJ; Pan QZ; Chen CL; Liu Y; Tang Y; Zhu Q; Weng DS; Xia JC
    J Immunother Cancer; 2019 Aug; 7(1):228. PubMed ID: 31455411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of adjuvant cytokine-induced killer cell immunotherapy in patients with colorectal cancer after radical resection.
    Pan QZ; Zhao JJ; Yang CP; Zhou YQ; Lin JZ; Tang Y; Gu JM; Wang QJ; Li YQ; He J; Chen SP; Song MJ; Huang Y; Yang JY; Weng DS; Xia JC
    Oncoimmunology; 2020; 9(1):1752563. PubMed ID: 32363125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective analysis of the efficacy of adjuvant cytokine-induced killer cell immunotherapy combined with chemotherapy in colorectal cancer patients after surgery.
    Li X; Zhou H; Huang W; Wang X; Meng M; Hou Z; Liao L; Tang W; Xie Y; Wang R; Yu H; Wang L; Zhu H; Wang W; Tan J; Li R
    Clin Transl Immunology; 2022; 11(1):e1368. PubMed ID: 35079378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of cytokine-induced killer cell infusion as an adjuvant therapy for postoperative hepatocellular carcinoma patients.
    Pan K; Li YQ; Wang W; Xu L; Zhang YJ; Zheng HX; Zhao JJ; Qiu HJ; Weng DS; Li JJ; Wang QJ; Huang LX; He J; Chen SP; Ke ML; Wu PH; Chen MS; Li SP; Xia JC; Zeng YX
    Ann Surg Oncol; 2013 Dec; 20(13):4305-11. PubMed ID: 23892527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the Clinical Efficacy of Dendritic Cell -cytokine Induced Killer Cell-based Adoptive Immunotherapy for Colorectal Cancer.
    Xu H; Qin W; Feng H; Song D; Yang X; Zhang J
    Immunol Invest; 2021 Aug; 50(6):622-633. PubMed ID: 32718264
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression-free survival for patients with hepatocellular carcinoma.
    Cui J; Wang N; Zhao H; Jin H; Wang G; Niu C; Terunuma H; He H; Li W
    Int J Cancer; 2014 Jan; 134(2):342-51. PubMed ID: 23825037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined cellular immunotherapy and chemotherapy improves clinical outcome in patients with gastric carcinoma.
    Cui J; Li L; Wang C; Jin H; Yao C; Wang Y; Li D; Tian H; Niu C; Wang G; Han W; Xu J; Chen J; Li W
    Cytotherapy; 2015 Jul; 17(7):979-88. PubMed ID: 25890480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking LLT1 (CLEC2D, OCIL)-NKRP1A (CD161) interaction enhances natural killer cell-mediated lysis of triple-negative breast cancer cells.
    Marrufo AM; Mathew SO; Chaudhary P; Malaer JD; Vishwanatha JK; Mathew PA
    Am J Cancer Res; 2018; 8(6):1050-1063. PubMed ID: 30034942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant treatment for triple-negative breast cancer: a retrospective study of immunotherapy with autologous cytokine-induced killer cells in 294 patients.
    Zhang Y; Wang S; Yang B; Lu S; Du Y; Liu H
    Cancer Biol Med; 2019 May; 16(2):350-360. PubMed ID: 31516755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine-induced killer cells/dendritic cells-cytokine induced killer cells immunotherapy combined with chemotherapy for treatment of colorectal cancer in China: a meta-analysis of 29 trials involving 2,610 patients.
    Zhang L; Mu Y; Zhang A; Xie J; Chen S; Xu F; Wang W; Zhang Y; Ren S; Zhou C
    Oncotarget; 2017 Jul; 8(28):45164-45177. PubMed ID: 28404886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the number and interval of treatment cycles on cytokine-induced killer cells and their adjuvant therapeutic effects in advanced non-small-cell lung cancer (NSCLC).
    Gu Y; Lv H; Zhao J; Li Q; Mu G; Li J; Wuyang J; Lou G; Wang R; Zhang Y; Huang X
    Int Immunopharmacol; 2017 Sep; 50():263-269. PubMed ID: 28711032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2003-2013, a valuable study: Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in stage IV breast cancer.
    Lin M; Liang S; Jiang F; Xu J; Zhu W; Qian W; Hu Y; Zhou Z; Chen J; Niu L; Xu K; Lv Y
    Immunol Lett; 2017 Mar; 183():37-43. PubMed ID: 28143792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capecitabine metronomic chemotherapy combined with autologous CIK cell immunotherapy in the treatment of recurrent and metastatic triple-negative breast cancer.
    Chen S; Yang Y; Jiao Y; Sun H; Yan Z
    J BUON; 2021; 26(3):734-740. PubMed ID: 34268928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy with cytokine-induced killer cells as an adjuvant treatment for advanced gastric carcinoma: a retrospective study of 165 patients.
    Zhao H; Fan Y; Li H; Yu J; Liu L; Cao S; Ren B; Yan F; Ren X
    Cancer Biother Radiopharm; 2013 May; 28(4):303-9. PubMed ID: 23506427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine-induced killer cell/dendritic cell combined with cytokine-induced killer cell immunotherapy for treating advanced gastrointestinal cancer.
    Du H; Yang J; Zhang Y
    BMC Cancer; 2020 Apr; 20(1):357. PubMed ID: 32345239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.